Engagement of -arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engagement of -arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 17, Pages E1028-E1037
Publisher
Proceedings of the National Academy of Sciences
Online
2012-04-10
DOI
10.1073/pnas.1112422109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin-like growth factors and risk of kidney cancer in men
- (2010) J M Major et al. BRITISH JOURNAL OF CANCER
- β-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonist
- (2010) Antonino Spartà et al. FEBS LETTERS
- Arrestin and the Multi-PDZ Domain-containing Protein MPZ-1 Interact with Phosphatase and Tensin Homolog (PTEN) and RegulateCaenorhabditis elegansLongevity
- (2010) Aimee Palmitessa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Involvement of Pregnancy-Associated Plasma Protein-A2 in Insulin-Like Growth Factor (IGF) Binding Protein-5 Proteolysis during Pregnancy: A Potential Mechanism for Increasing IGF Bioavailability
- (2010) Xiaolang Yan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GABAB Receptor Activation Protects Neurons from Apoptosis via IGF-1 Receptor Transactivation
- (2010) H. Tu et al. JOURNAL OF NEUROSCIENCE
- Teaching old receptors new tricks: biasing seven-transmembrane receptors
- (2010) Sudarshan Rajagopal et al. NATURE REVIEWS DRUG DISCOVERY
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- β-Arrestin Mediates β1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling
- (2009) Douglas G. Tilley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
- (2009) J. S.P. Yuen et al. MOLECULAR CANCER THERAPEUTICS
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R)
- (2009) Davide Bolignano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell
- (2008) Alexander Korzh et al. BRAIN RESEARCH
- Sustained Elevated Levels of Circulating Vasopressin Selectively Stimulate the Proliferation of Kidney Tubular Cells via the Activation of V2Receptors
- (2008) Gérard Alonso et al. ENDOCRINOLOGY
- Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells
- (2008) Mami Tsuchioka et al. JOURNAL OF NEUROCHEMISTRY
- Conformational Rearrangements and Signaling Cascades Involved in Ligand-Biased Mitogen-Activated Protein Kinase Signaling through the 1-Adrenergic Receptor
- (2008) S. Galandrin et al. MOLECULAR PHARMACOLOGY
- Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney Disease
- (2007) X. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More